Correlation Between Pharmacielo and Sunniva
Can any of the company-specific risk be diversified away by investing in both Pharmacielo and Sunniva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmacielo and Sunniva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmacielo and Sunniva, you can compare the effects of market volatilities on Pharmacielo and Sunniva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmacielo with a short position of Sunniva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmacielo and Sunniva.
Diversification Opportunities for Pharmacielo and Sunniva
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pharmacielo and Sunniva is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmacielo and Sunniva in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunniva and Pharmacielo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmacielo are associated (or correlated) with Sunniva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunniva has no effect on the direction of Pharmacielo i.e., Pharmacielo and Sunniva go up and down completely randomly.
Pair Corralation between Pharmacielo and Sunniva
Assuming the 90 days horizon Pharmacielo is expected to generate 6.73 times less return on investment than Sunniva. But when comparing it to its historical volatility, Pharmacielo is 4.19 times less risky than Sunniva. It trades about 0.03 of its potential returns per unit of risk. Sunniva is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 0.00 in Sunniva on October 11, 2024 and sell it today you would earn a total of 0.00 from holding Sunniva or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 99.6% |
Values | Daily Returns |
Pharmacielo vs. Sunniva
Performance |
Timeline |
Pharmacielo |
Sunniva |
Pharmacielo and Sunniva Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pharmacielo and Sunniva
The main advantage of trading using opposite Pharmacielo and Sunniva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmacielo position performs unexpectedly, Sunniva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunniva will offset losses from the drop in Sunniva's long position.Pharmacielo vs. Amexdrug | Pharmacielo vs. The BC Bud | Pharmacielo vs. Speakeasy Cannabis Club | Pharmacielo vs. Benchmark Botanics |
Sunniva vs. City View Green | Sunniva vs. Benchmark Botanics | Sunniva vs. Pharmacielo | Sunniva vs. Amexdrug |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Valuation Check real value of public entities based on technical and fundamental data |